生命科学资讯

FDA may consider Moderna's flu vaccine in a narrower group

Former AstraZeneca senior staff charged with illegal trade in China

Prasad overruled vaccine review team, office director on Moderna flu shot

After CEO departs, CSL details profit crash, $1.1B impairment costs

Madrigal pads MASH pipeline with six siRNAs from China's Ribo

Gubra forms venture unit; Galecto's $275M offering

How a closet full of EKG machines illustrates pharma’s clinical trial cost problem

Oscar Health expects explosive growth for 2026, but it comes with a risk

Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?

Upstream Bio says verekitug delivered positive data in Phase 2 severe asthma trial

Moderna accuses FDA of shifting standard as agency refuses flu shot review

Isomorphic claims major advance with new AI drug design engine

ILiAD raises $115M round to advance whooping cough vaccine

AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fight

NIH stops low-dose Xarelto arm of large stroke study due to safety concerns

Is AstraZeneca on track to meet its $80B revenue target?

The fallout from Novo vs. Hims

Shanghai's Cascade gets $72M to pursue MASH, obesity and diabetes drugs

Nektar posts one-year eczema success; Pfizer ends malnutrition trial

CSL’s Paul McKenzie out, as Gordon Naylor named interim CEO